Clinical trial Recruiting at 1 site Interventional Ages 18 to 64

Online DBT-informed skills program to help adult smokers quit and manage distress

Official title: Effect of an Internet-based Dialectical Behaviour Therapy-informed Skills Training for Promoting Smoking Cessation and Improving Psychological Distress of Smokers: A Pilot Randomised Controlled Trial

Run by Chinese University of Hong Kong · NCT06575673 · Data updated 2026-11-12

This program will try an online DBT-informed skills course to help adult smokers quit or cut down and feel less psychological distress.

More Smoking trials

Quick facts

Study typeInterventional
Ages18 Years to 64 Years
SexAll
Enrollment60 (estimated)
SponsorChinese University of Hong Kong
Academic / other
Locations2 sites (Tai Po, New Territories and 1 other locations)
StatusRecruiting
StartedSeptember 4, 2024
Main results expectedSeptember 2025
Study endsDecember 2025
Registry record updatedSeptember 22, 2025
Trial IDNCT06575673 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are Hong Kong Chinese adults aged 18–64 who smoke at least one cigarette daily, have elevated distress on the DASS-21, want to quit, and can use internet-capable devices.

Probably not a fit

People with psychotic disorders, significant cognitive or communication impairments, those already in other smoking cessation programs, or those without internet access are unlikely to benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot interventional project delivers dialectical behaviour therapy–informed skills training via the internet, with monthly health education as a comparator/support. It enrolls Hong Kong Chinese adults aged 18–64 who smoke daily, report psychological distress on the DASS-21, intend to stop smoking, and have internet access. Outcomes include feasibility and acceptability measures, preliminary effects on smoking abstinence or reduction and on psychological distress and emotional regulation, plus qualitative interviews about participants' experiences. The design emphasizes remote delivery to increase accessibility while recruiting through Hospital Authority sites in Tai Po and Hong Kong.

Why it matters

Potential benefit: If successful, the program could provide an accessible online option to help smokers with emotional distress quit or reduce smoking and improve emotional regulation.

How similar studies have gone: Previous DBT-informed and internet-based smoking interventions have shown promise for people with emotional dysregulation, but fully online DBT skills training specifically for smoking cessation is relatively novel and less studied.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Hong Kong Chinese aged 18-64 years
* Had smoked at least one cigarette per day over the previous three months
* Indicate psychological distress as measured by the Depression, Anxiety, and Stress Scale-21
* Have an intention to stop smoking
* Have an electronic device and are willing to receive interventions via the internet

Exclusion Criteria:

* Experiencing psychotic disorders/cognitive impairment/communication problems
* Participating in other smoking cessation programs or related psychosocial interventions

Where it's running

  • Hospital Authority
    Tai Po, New Territories, Hong Kong
    Recruiting
  • Hospital Authority
    Hong Kong, Hong Kong
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.